Remove 2023 Remove Generic Medicine Remove Pharmaceutical Companies
article thumbnail

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects. He has been advising pharmaceutical companies and healthcare providers for a number of years.

article thumbnail

What a mild recession could mean for small biotechs in 2023

Pharmaceutical Technology

in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Furthermore, for months, several financial institutions such as Bank of America and JP Morgan have been talking of a “mild recession” in 2023 for the US. by the end of 2023 and may continue to rise in 2024 to 5%.